Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter “Carillon Eagle ...
U.S. stocks are ticking higher and once again flirting with a record following mixed profit reports from big companies. The S ...
On a frigid North Dakota afternoon, a steaming bowl of their soup feels like a warm blanket for your insides. Breakfast brings in the early crowd who know where to find a proper morning meal. Eggs ...
Pilgrim's Pride Corporation (NASDAQ: PPC), one of the world's leading food companies, reports its fourth quarter and year-end 2025 financial results.
First and Only CD19-Targeted Therapy Approved in Europe for Adults with anti-AChR+ and anti-MuSK+ gMGUPLIZNA Demonstrates Durable Disease Control with Twice-Yearly Dosing*THOUSAND OAKS, Calif.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results